COL23A1 Antibody (C-10): sc-514835. Western blot analysis of COL23A1 expression in NCI-H460 whole cell lysate (A) and human thymus (B), human placenta (C), human brain (D), human testis (E) and human lung (F) tissue extracts.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
COL23A1 Antibody (C-10): sc-514835. Western blot analysis of COL23A1 expression in NCI-H460 whole cell lysate (A) and human thymus (B), human placenta (C), human brain (D), human testis (E) and human lung (F) tissue extracts.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
COL23A1 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the COL23A1 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: COL23A1 Antibody (C-10): sc-514835